- Global Pharma News & Resources

Digital PCR and Real-time PCR (qPCR) Market 2020 Global Trends, Sales Revenue, Development Strategy, Key Vendors, Competitive Landscape, Opportunity Assessment and Potential of The Industry Till 2026

Global Digital PCR and Real-time PCR (qPCR) Market

The polymer chain reaction (PCR) technique enables the creation of unlimited copies of DNA from a single strand of DNA, with the help of polymerase enzymes, primers, and multiple thermal cycles. PCR diagnostics are less prone to cross-contamination, as the procedure is conducted in automated thermal cyclers. Therefore, these are common diagnostic techniques used in research, pharma, and biotech institutes, and have a wide range of application in various sectors.

Request Sample Copy of the Business Report:

Real-time PCR allows specific and early disease diagnosis, while also enabling speedy and selective treatment of the patient. The PCR techniques have replaced several conventional infectious disease detection methods, such as immunoassays, as they are more specific and have become an integral part of laboratory diagnosis. Hence, all the aforementioned factors are said to facilitate the global digital PCR and real-time PCR market growth.

Global Digital PCR and Real-time PCR (qPCR) Market Dynamics

Increasing adoption of qPCR in medical diagnosis to detect RNA viruses, such as HIV and hepatitis C, is expected to propel the global digital PCR and real-time PCR market development. According to the International Journal of Nanomedicine, in 2017, around 36.7 million people worldwide were affected by the human immunodeficiency virus (HIV), while up to 400 million people suffered from viral hepatitis. The survey further stated that, early diagnosis is a critical factor in managing AIDS patients, as there is no reliable treatment the HIV infection. Moreover, the launch of technologically advanced products would fuel the market growth, according to the latest report. For instance, in November 2013, GNA Biosolutions GmbH launched an ultrafast PCR platform, Pharos V8 platform based on laser PCR. The platform uses nanomaterial to accelerate PCR reaction, by a factor of ten, thus making it suitable to be used in time-sensitive settings.

However, high costs of devices and rising adoption of alternative assays for disease detection and analysis are significant aspects predicted to hinder the global market growth.

Tailored Information as per niche requirement:

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @

Global Digital PCR and Real-time PCR (qPCR) Market – Regional Analysis

North America is expected to hold a dominant position in the global digital PCR and real-time PCR market, owing to the increasing number of cancer cases, which is consecutively increasing the demand for PCR diagnostic tools and assays in the region. According to the National Cancer Institute, an estimated 1,735,350 million new cancer cases were diagnosed in the U.S. in 2016, with around 609,640 deaths resulting from the disease in 2018. However, the figure is expected to rise up to a staggering 19 million by 2024.

Global Digital PCR and Real-time PCR (qPCR) Market – Key Players

The major players operating in the global digital PCR and real-time PCR market include Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Qiagen N.V., Takara Bio, Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson and Company, and Agilent Technologies, Inc.

Key Developments

  • In April 2019, Thermo Fisher Scientific Inc. introduced Applied Biosystems QuantStudio 6 and 7 Pro Real-Time PCR Systems, which includes new specifications like facial authentication, voice command and radiofrequency identification.
  • In January 2019, QIAGEN N.V. announced the development of range of next-generation systems for the digital polymerase chain reaction (digital PCR or dPCR) one of the fastest-growing molecular testing applications, which is expected to launch in 2020.
  • In 2017, Bio-Rad Laboratories, Inc. introduced iQ-Check Enterobacteriaceae real-time PCR detection kit that can be used for 94 samples.
  • In 2017, Agilent Technologies Inc. launched AriaDx Real-Time PCR System for Clinical Diagnostics in Europe to expand its molecular diagnostic portfolio.
  • In 2016, Danaher Corporation acquired Cepheid Inc. to expand its qPCR-product portfolio.

To understand Research Methodology, please click

Global Digital PCR and Real-time PCR (qPCR) Market Taxonomy

By Technology:

  • Quantitative PCR (qPCR)
  • Digital PCR (dPCR)

By Product Type:

  • Reagents and Consumables
  • Instruments

By Application:

  • Clinical
    • Pathogen Testing
    • Oncology Testing
    • Blood Screening
    • Others
  • Research
  • Forensic

By End User:

  • Hospitals and Diagnostic Centers
  • Academic & Research Institutes
  • Pharmaceutical and Biotechnology Industries
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website –


Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 05-Feb-2021